Tesla's Trillion-Dollar Tab Looms Over Earnings

Tesla shares jumped 12% on a UBS upgrade, but weak Q1 deliveries and a massive new $25B+ Terafab chip plant project create major financial uncertainty ahead of earnings.

Tesla shares surged over 12% this week, buoyed by an analyst upgrade, yet the rally masks a colossal financial question overshadowing the company's imminent quarterly report. UBS shifted its rating on the stock from "Sell" to "Neutral," citing an improved risk-reward profile after recent declines and maintaining a $352 price target. The stock jumped over six percent on the news to trade at 328.85 euros. However, this optimism collides with weak operational data and the unveiling of a capital project so vast it could redefine the company's financial future.

The core concern is Terafab. Announced jointly by Tesla and SpaceX on March 21, this semiconductor plant in Austin, Texas, promises an annual computing power of one terawatt. With Intel joining as a partner on April 7, earthworks are already underway. The initial investment is pegged at $25 billion, but analysts warn the final bill could be astronomically higher. Barclays, which rates Tesla "Equal Weight" with a $360 target, fears the fully built facility could cost several trillion dollars. Morgan Stanley estimates building significant chip capacity alone at $35 to $45 billion. This creates a stark contrast with Tesla's financials; the company generated free cash flow of $6.22 billion in 2025.

Crucially, CFO Vaibhav Taneja confirmed that Terafab is not included in the existing capital expenditure guidance of $20 billion for 2026, with a separate update promised later. This leaves investors facing an open-ended multi-billion, or even trillion-dollar, commitment.

Operational results provide no cushion. Tesla's first-quarter vehicle deliveries of 358,023 units missed market expectations of 372,000. Production of 408,386 vehicles meant over 50,000 units swelled inventory. The company has also ended production of its older Model S and X, a move that alienated parts of its luxury clientele as it pivots toward robotics. The energy storage business fared worse, with installations crashing 38% quarter-over-quarter to 8.8 GWh, far below the 14.4 GWh analysts anticipated.

The primary culprit is well-known: the expiration of the US federal EV tax credit of $7,500 at the end of 2025 pulled demand forward, leaving a gap at the start of 2026. To meet its annual targets, Tesla must now deliver an average of 444,000 vehicles per quarter for the rest of the year—a level it hasn't consistently hit since 2023.

Wall Street's outlook on the stock remains deeply fractured. While Wedbush sees a $600 price target and Morgan Stanley's Adam Jonas holds at $410, Wells Fargo's target sits at just $125. TD Cowen expects no guidance cut and a slightly positive setup into the earnings call. The stock's recent 11% gain over seven days has pushed its RSI to 70.4, technically entering overbought territory, and it remains about 21% below its 52-week high.

For the quarter ending March 31, analysts expect earnings per share of $0.24, a 60% increase year-over-year, though estimates range widely from $0.09 to $0.44. Prediction markets currently see only a 47% chance of results exceeding expectations.

Long-term projects like robotaxis and the Optimus humanoid robot also face skepticism. UBS doubts the rapid scaling of a planned nine-city robotaxi network by mid-2026 and projects only 5,000 Optimus units in 2027, slower than CEO Elon Musk's timeline. The bank warns the stock is trading more on sentiment than fundamentals amid weak EV demand and rising costs.

When Tesla reports on April 22, the discussion will extend beyond gross margins and the $20 billion capex plan. Elon Musk must articulate a credible financial strategy for Terafab—a project with a potential price tag in the trillions—without jeopardizing Tesla's cash flow. That answer may ultimately move the stock more than any earnings surprise.